During the last session, Core Scientific Inc (NASDAQ:CORZ)’s traded shares were 11.17 million, with the beta value of the company hitting 6.49. At the end of the trading day, the stock’s price was $10.78, reflecting an intraday loss of -4.43% or -$0.5. The 52-week high for the CORZ share is $18.63, that puts it down -72.82 from that peak though still a striking 58.63% gain since the share price plummeted to a 52-week low of $4.46. The company’s market capitalization is $3.21B, and the average trade volume was 16.78 million shares over the past three months.
Core Scientific Inc (CORZ) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.17. CORZ has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.0.
Core Scientific Inc (NASDAQ:CORZ) trade information
Core Scientific Inc (CORZ) registered a -4.43% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.43% in intraday trading to $10.78, hitting a weekly high. The stock’s 5-day price performance is -1.28%, and it has moved by 30.83% in 30 days. Based on these gigs, the overall price performance for the year is 158.51%.
The consensus price target of analysts on Wall Street is $22, which implies an increase of 51.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20 and $24 respectively. As a result, CORZ is trading at a discount of -122.63% off the target high and -85.53% off the low.
Core Scientific Inc (CORZ) estimates and forecasts
In the rating firms’ projections, revenue will decrease -16.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 82.09M as predicted by 15 analyst(s). Meanwhile, a consensus of 15 analyst(s) estimates revenue growth to 110.06M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 141.1M and 95.35M respectively. In this case, analysts expect current quarter sales to shrink by -41.82% and then jump by 15.43% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -1117.00%. While earnings are projected to return 131.03% in 2025.
CORZ Dividends
Core Scientific Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Core Scientific Inc (NASDAQ:CORZ)’s Major holders
The next largest institutional holding, with 9.75 million shares, is of VANGUARD GROUP INC’s that is approximately 5.4613% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $90.66 million.
Also, the Mutual Funds coming in first place with the largest holdings of Core Scientific Inc (CORZ) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 7.92 shares. This amounts to just over 2.66 percent of the company’s overall shares, with a $85.42 million market value. The same data shows that the other fund manager holds slightly less at 4.76, or about 1.60% of the stock, which is worth about $51.32 million.
